Figure 4 summarizes the anti-cancer effects of bergaptol, which include blocking transcription factors, e.g., STAT3, modulating apoptotic regulators, e.g., BAX/BCL2, stabilizing cell-cycle inhibitors, e.g., p27, and blocking p-glycoprotein-mediated drug efflux. Here, STAT3 is linked to cancer.